RecruitingNot Applicable

Systematic Evaluation of Psychotherapy Training: Supervision, Student Learning, and Patient Outcomes

Sweden417 participantsStarted 2023-12-01

Plain-language summary

The project is a longitudinal observation study that aims to systematically evaluate selected parts of the material collected within the framework of the psychotherapy training conducted at the Center of Psychotherapy Education and Research unit at Karolinska Institutet and Region Stockholm, Sweden. Students at the unit, patients being administered psychotherapy by the students, and supervisors will participate in the study. The aim of the present study is to investigate the associations between (1) content and quality of psychotherapy supervision, (2) student therapists' competence, and (3) patient outcomes following student-led psychotherapy.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Students at one of the following courses/programs: Primary training in evidence-based psychotherapeutic methods (three semesters) and specialty trainee (ST) for doctors in child, adolescent, and adult psychiatry (two semesters), the postgraduate psychotherapist program (six semesters), and the specialist training program for clinical psychologists (six semesters). * Clinical supervisors for the students in the abovementioned courses/programs. * Patients in psychotherapy with students in the abovementioned courses/programs as therapists. The patients are regular patients at public health care facilities in psychiatry and primary care. * Students, supervisors, and patients must consent to inclusion. Exclusion Criteria: * No exclusion criteria are applied.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The Generalized Anxiety Disorder Assessment 7 (GAD-7)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Patient Health Questionnaire-9 (PHQ-9)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The WHO Disability Assessment Schedule (WHODAS 2.0)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Alcohol Use Disorders Identification Test (AUDIT)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy for those patients scoring above the cut-off at pre-treatment

The Sleep Condition Indicator (SCI)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Liebowitz Social Anxiety Scale, self-report (LSAS-SR)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

Trial details

NCT IDNCT06105502

SponsorRegion Stockholm

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2028-12-31

Contact for this trial

Maria Beckman, PhD

+46-70-797 22 65 maria.beckman@ki.se

View on ClinicalTrials.gov More Student Education trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The Generalized Anxiety Disorder Assessment 7 (GAD-7)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Patient Health Questionnaire-9 (PHQ-9)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The WHO Disability Assessment Schedule (WHODAS 2.0)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Alcohol Use Disorders Identification Test (AUDIT)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy for those patients scoring above the cut-off at pre-treatment

The Sleep Condition Indicator (SCI)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy

The Liebowitz Social Anxiety Scale, self-report (LSAS-SR)

Timeframe: Change from pre-treatment to immediately after the end of psychotherapy